Manufacturers increasingly need to think about "cradle to grave" expenses for products. A new example arises from drugs. Some people link drugs in water to various diseases. Therefore, some want better disposal of unused drugs – some of the facts are outlined in a brief article from Harvard online.
Now, in a next step, a federal judge this week upheld a statute requiring drug manufacturers to bear the expense of "take back" programs intended to replace sloppy disposal. The opinion is online, courtesy of AmLaw. An article from the Recorder explains: